Por: ABC7 Health September 20, 2023
on Tuesday.ARS shares fell sharply on Wednesday, dropping about 58% in pre-market trading.ABC News' Sony Salzman contributed to this story.This is a developing story. Please check back for updates.... + full article
10 WBNS USA Health September 21, 2023
WASHINGTON — Federal regulators declined to approve a nasal spray to treat severe allergic reactions late Tuesday, calling for more research on what would have been the first alternative to injections using devices such as an EpiPen. The U.S. Food and Drug Administration told... + más
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
CBS News USA Politics September 20, 2023
The Food and Drug Administration declined on Tuesday to approve neffy, an epinephrine nasal spray from drugmaker ARS Pharmaceuticals, keeping the first needle-free option for Americans to treat severe allergic reactions off the market pending more trial data.ARS had expected the... + más
First epinephrine nasal spray clears key FDA hurdle, promising needle-free alternative | CBS News
FDA denies nasal spray alternative to EpiPen | WPTV
RTTNews USA Health July 31, 2023
The U.S. Food and Drug Administration approved Harm Reduction Therapeutics' RiVive, 3 milligram naloxone hydrochloride nasal spray for over-the-counter or OTC, nonprescription use for the emergency treatment of known or suspected opioid overdose.The agency's second... + más
FDA approves nonprofit's over-the-counter opioid overdose nasal spray | WPTV
Availability Of Over-The-Counter Narcan Could Help As A Tool To Combat The Illicit Fentanyl Crisis, But Affordability Remains An Issue | Forbes
CBS News USA Politics May 12, 2023
A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free option for treating severe allergic reactions.The majority backing the spray... + más
In-flight emergencies raise concerns about airlines' medical kit requirements | CBS News
Doctor calling for FAA, Southwest changes after midair scare | ABC News
New York Post USA Life March 29, 2023
On Wednesday, the Food and Drug Administration approved the first over-the-counter nasal spray that rapidly reverses the effects of an opioid overdose. Narcan, a 4-milligram naloxone hydrochloride nasal spray, will not require a prescription and will be available in... + más
FDA approves first over-the-counter Narcan | Politico
F.D.A. Approves Narcan for Over-the-Counter Sales | The New York Times
Politico USA Health October 15, 2022
Biden administration officials are raising concerns that the slow pace of developing a nasal vaccine for Covid-19 in the U.S. could pose a security risk as China, Iran and Russia approve their own vaccines taken through the nose or mouth. Though nasal and oral vaccines are being... + más
Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica
Nasal COVID vaccine fails to offer desired protection in testing | The Hill
Ars Technica USA Science October 12, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 12, 2022 5:17 pm UTC / A man receives an H1N1 nasal flu spray vaccine at an urgent care center on October 16, 2009, in Lake... + más
Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes
About iurex | Privacy Policy | Disclaimer |